We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNI
1301
DELISTED
The McClatchy Company Class A Common Stock
MNI
$74K 0.01%
5,098
+3,384
+197% +$40.4K
CBU icon
1302
Community Bank
CBU
$3.41B
$73K 0.01%
+1,779
New +$70.6K
COLO
1303
Global X MSCI Colombia ETF
COLO
$213M
$73K 0.01%
+2,006
New +$72.3K
HHH icon
1304
Howard Hughes
HHH
$4B
$73K 0.01%
+671
New +$68.9K
NWN icon
1305
Northwest Natural Holdings
NWN
$2.12B
$73K 0.01%
1,128
+928
+464% +$51.7K
TK icon
1306
Teekay
TK
$991M
$73K 0.01%
10,247
+8,227
+407% +$77.2K
CBD
1307
DELISTED
Companhia Brasileira de Distribuicao
CBD
$73K 0.01%
5,003
+3,704
+285% +$48.8K
CSII
1308
DELISTED
Cardiovascular Systems, Inc.
CSII
$73K 0.01%
+4,008
New +$62.6K
NTUS
1309
DELISTED
Natus Medical Inc
NTUS
$73K 0.01%
1,928
+1,867
+3,061% +$62.5K
SDRL
1310
DELISTED
Seadrill Limited Common Stock
SDRL
$73K 0.01%
84
+83
+8,300% +$78.9K
BBU
1311
DELISTED
Brookfield Business Partners
BBU
$72K 0.01%
+5,905
New +$75.3K
GRP.U
1312
DELISTED
Granite Real Estate Investment Trust
GRP.U
$72K 0.01%
+2,400
New +$71.3K
HPQ icon
1313
HP
HPQ
$26.6B
$72K 0.01%
5,780
+3,768
+187% +$46.9K
LE icon
1314
Lands' End
LE
$402M
$72K 0.01%
4,419
+3,976
+898% +$80.5K
LNN icon
1315
Lindsay Corp
LNN
$1.17B
$72K 0.01%
1,060
+910
+607% +$64.7K
NBTB icon
1316
NBT Bancorp
NBTB
$2.75B
$72K 0.01%
+2,512
New +$70.6K
RUSHA icon
1317
Rush Enterprises Class A
RUSHA
$9.52B
$72K 0.01%
7,434
+981
+15% +$8.69K
SLV icon
1318
iShares Silver Trust
SLV
$31.5B
$72K 0.01%
4,012
-5,075
-56% -$81.2K
VVX icon
1319
V2X
VVX
$2.52B
$72K 0.01%
2,495
+2,129
+582% +$51K
PRFT
1320
DELISTED
Perficient Inc
PRFT
$72K 0.01%
+3,543
New +$73.4K
TCO
1321
DELISTED
Taubman Centers Inc.
TCO
$72K 0.01%
974
+396
+69% +$27.9K
VSI
1322
DELISTED
Vitamin Shoppe Inc.
VSI
$72K 0.01%
2,347
+1,647
+235% +$48.8K
KEM
1323
DELISTED
KEMET Corporation
KEM
$72K 0.01%
24,598
+10,888
+79% +$27K
ALSN icon
1324
Allison Transmission
ALSN
$10.3B
$71K 0.01%
2,508
+2,485
+10,804% +$69K
ASRT
1325
DELISTED
Assertio
ASRT
$71K 0.01%
+60
New +$65.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.